Sapreme in a €15M series A backed by Aglaia BioMedical Ventures
07 October 2021
07 October 2021
Total investments received (USD): 17.4m
Round value (USD): 17.4m
Round investors:
Aglaia BioMedical Ventures
Company: Sapreme
Related deals
Amber Implants closes $10 million Series A round backed by Blue Sparrows MedTech Funds.
Investments
15 January 2022
Onera Health to raise €10.5M series B led by Innovation Industries
Investments
16 July 2021
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom